株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

実験動物モデル、3次元培養およびオルガノイドの世界市場

Laboratory Animal Models, 3D Cultures and Organoids

発行 BCC Research 商品コード 807093
出版日 ページ情報 英文 198 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.06円で換算しております。
Back to Top
実験動物モデル、3次元培養およびオルガノイドの世界市場 Laboratory Animal Models, 3D Cultures and Organoids
出版日: 2019年03月08日 ページ情報: 英文 198 Pages
概要

世界における実験動物モデルの市場規模は、2018年の59億米ドルから2023年までに78億米ドルへ拡大すると予測され、この間は5.6%のCAGR (年間複合成長率) が予測されています。

当レポートでは、世界の実験動物モデル、3次元培養 (3D培養) およびオルガノイド市場について調査分析し、市場概要、技術の背景、市場動向分析と予測、競合情勢、主要企業などについて、体系的な情報を提供しています。

第1章 イントロダクション

第2章 サマリー・ハイライト

第3章 動物モデル市場の技術背景

  • 動物モデルおよび3次元細胞培養修正の方法
  • 実験動物モデル

第4章 3次元細胞培養市場の分析:技術別

  • 3次元細胞培養
  • 再生医療・バイオプリンティング
  • マイクロ流体生体機能チップ (Organ-on-Chip) プラットフォーム

第5章 オルガノイド市場の分析:技術別

  • オルガノイド

第6章 市場分析:エンドユーザー別

  • 動物モデル:エンドユーザー別
  • 3次元細胞培養:エンドユーザー別

第7章 市場分析:用途別

  • 創薬、癌研究およびオーダーメイド医療
  • 毒性・安全性検査

第8章 市場分析:地域別

  • アジア太平洋
  • 北米
  • 欧州
  • 中東・アフリカ (MEA)
  • 南米

第9章 特許レビュー/新規開発

第10章 市場機会の分析

  • 市場機会:動物モデル
  • 市場機会:3次元細胞培養セグメント
  • 3次元細胞培養・動物モデルのメリット・デメリット

第11章 企業・重要機関のプロファイル

  • 動物モデル企業
    • ALPHAGENESIS INC.
    • CHARLES RIVER LABORATORIES INTERNATIONAL INC.
    • COVANCE INC.
    • CROWN BIOSCIENCE INC.
    • ENVIGO
    • GENOWAY S.A.
    • JACKSON LABORATORY
    • JANVIER LABS
    • OAK HILL GENETICS
    • PRIMGEN
    • TACONIC BIOSCIENCES
    • TRANSGENIC INC.
    • TRANSPOSAGEN BIOPHARMACEUTICALS INC.
  • バイオプリンティング・再生医療企業
    • ALLEVI
    • ASPECT BIOSYSTEMS LTD.
    • BIOINK SOLUTIONS INC.
    • CELLINK INC.
    • COLLPLANT HOLDINGS LTD.
    • EAST RIVER BIOSOLUTIONS/XYLYX BIO
    • EPIBONE
    • MATTEK CORP.
    • NANO 3D BIOSCIENCES INC.
    • ORGANOVO HOLDINGS INC.
    • PEPGEL LLC
    • REGENHU
    • TEVIDO BIODEVICES INC.
    • TISSUSE GMBH
  • 生体機能チップ (Organ-on-Chip) 企業
    • AXOSIM
    • EMULATE, INC.
    • KIRKSTALL LTD.
    • MICRONIT MICROTECHNOLOGIES
    • MIMETAS
    • TARA BIOSYSTEMS INC.
  • オルガノイド企業
    • 3DNAMICS
    • CELLESCE
    • CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER
    • HUBRECHT ORGANOID TECHNOLOGY
    • QGEL
    • R&D SYSTEMS INC.
    • STEMCELL TECHNOLOGIES INC.
    • TREVIGEN INC.
  • その他の3次元細胞培養企業
    • 3D BIOTEK LLC
    • ADVANCED BIOMATRIX INC.
    • HORIZON DISCOVERY GROUP PLC
    • IN SPHERO INC.
    • MERCK & CO., INC.
    • PROMOCELL GMBH
    • REPROCELL INC.
    • SYNTHECON, INC.
図表

List of Tables

  • Summary Table A: Global Market for Laboratory Animal Models, by Type, Through 2023
  • Summary Table B: Global Market for Organs-on-Chips and Organoids, Through 2023
    • Table 1: Global Market for Laboratory Mice, by Region, Through 2023
    • Table 2: Global Market for Laboratory Rats, by Region, Through 2023
    • Table 3: Global Market for Laboratory Guinea Pigs, by Region, Through 2023
    • Table 4: Global Market for Laboratory Rabbits, by Region, Through 2023
    • Table 5: Global Market for Laboratory Hamsters, by Region, Through 2023
    • Table 6: Global Market for Laboratory Cats, by Region, Through 2023
    • Table 7: Global Market for Laboratory Dogs, by Region, Through 2023
    • Table 8: Global Market for Laboratory Pigs, by Region, Through 2023
    • Table 9: Global Market for Laboratory Nonhuman Primates, by Region, Through 2023
    • Table 10: Tissue Engineering Related Search Terms in PubMed, Through 2018
    • Table 11: Tissue Bioprinting Related Search Terms in PubMed, Through 2018
    • Table 12: Organ-on-Chip Related Search Terms in PubMed, Through 2018
    • Table 13: Investments in Organ-on-Chip Technology, by Company, Through 2018
    • Table 14: Global Market for Organs-on-Chips, Through 2023
    • Table 15: Organoid Types Mentioned in PubMed Articles, Through 2018
    • Table 16: Mentions of Spheroids in PubMed Articles, Through 2018
    • Table 17: Organoid Centers
    • Table 18: Global Market for Organoids, by Type, Through 2023
    • Table 19: Global Market for Animal Models, by End User, Through 2023
    • Table 20: Continents Banning Animal Testing for Cosmetics, by Country and Year Banned, 2013-2019
    • Table 21: Asia-Pacific Market for Laboratory Animal Models, by Type, Through 2023
    • Table 22: Australian Market for Laboratory Animal Models, by Type, Through 2023
    • Table 23: Chinese Market for Laboratory Animal Models, by Type, Through 2023
    • Table 24: Japanese Market for Laboratory Animal Models, by Type, Through 2023
    • Table 25: North American Market for Laboratory Animal Models, by Type, Through 2023
    • Table 26: U.S. Market for Laboratory Animal Models, by Type, Through 2023
    • Table 27: Canadian Market for Laboratory Animal Models, by Type, Through 2023
    • Table 28: Mexican Market for Laboratory Animal Models, by Type, Through 2023
    • Table 29: European Market for Laboratory Animal Models, by Type, Through 2023
    • Table 30: Great Britain Market for Laboratory Animal Models, by Type, Through 2023
    • Table 31: German Market for Laboratory Animal Models, by Type, Through 2023
    • Table 32: French Market for Laboratory Animal Models, by Type, Through 2023
    • Table 33: Rest of European Market for Laboratory Animal Models, by Type, Through 2023
    • Table 34: Middle Eastern and African Market for Laboratory Animal Models, by Type, Through 2023
    • Table 35: Israeli Market for Laboratory Animal Models, by Type, Through 2023
    • Table 36: South American Market for Laboratory Animal Models, by Type, Through 2023
    • Table 37: Brazilian Market for Laboratory Animal Models, by Type, Through 2023
    • Table 38: Review of Selected Patents and Patent Applications on Laboratory Animal Models, 2006-2018
    • Table 39: Global Number of Transplanted Organs, by Country, 2017
    • Table 40: Charles River Laboratories: Segments
    • Table 41: Charles River Laboratories: Revenue, 2013-2017
    • Table 42: Charles River Laboratories: RMS Company Yearly Revenues/Operating Income, by Quarter, 2016 and 2017
    • Table 43: Charles River Laboratories: Company Business Structure Data, by Segment, 2017
    • Table 44: Crown Bioscience Inc.: Segments
    • Table 45: Envigo: Segments
    • Table 46: Envigo: Consolidated Revenue, by Segment, 2015-2018
    • Table 47: Envigo: RMS Quarterly Revenue, 2015-2018
    • Table 48: Envigo: Types of Laboratory Animals
    • Table 49: Genoway S.A.: Segments
    • Table 50: Genoway S.A.: Sales, 2016 and 2017
    • Table 51: Jackson Laboratory: Segments
    • Table 52: Jackson Laboratory: Company Data, 2013-2016
    • Table 53: Janvier Labs: Segments
    • Table 54: Taconic Biosciences: Segments
    • Table 55: Transgenic Inc.: Segments
    • Table 56: Transgenic Inc.: Company Data, 2014-2018
    • Table 57: Transposagen Biopharmaceuticals Inc.: Segments
    • Table 58: Organovo: Expenses on R&D, 2013-2018
    • Table 59: 3D Biotek LLC: Segments
    • Table 60: In Sphero Inc.: Segments
    • Table 61: Merck & Co., Inc.: Revenue, by Region
    • Table 62: Merck & Co., Inc.: Company Data, 2013-2017
    • Table 63: Reprocell Inc.: Acquisitions

List of Figures

  • Summary Figure A: Global Market for Laboratory Animal Models, by Type, 2016-2023
  • Summary Figure B: Global Market for Organ-on-Chip and Organoids, 2017-2023
    • Figure 1: PubMed Timeline for the Mesh Terms of Types of Mice, 2000-2017
    • Figure 2: Global Market for Laboratory Mice, by Region, 2016-2023
    • Figure 3: PubMed Timeline for the Mesh Terms of Types of Rats, 2000-2017
    • Figure 4: Global Market for Laboratory Rats, by Region, 2016-2023
    • Figure 5: Global Market for Laboratory Guinea Pigs, by Region, 2016-2023
    • Figure 6: Global Market for Laboratory Rabbits, by Region, 2016-2023
    • Figure 7: Global Market for Laboratory Hamster, by Region, 2016-2023
    • Figure 8: Global Market for Laboratory Cats, by Region, 2016-2023
    • Figure 9: Global Market for Laboratory Dogs, by Region, 2016-2023
    • Figure 10: Global Market for Laboratory Pigs, by Region, 2016-2023
    • Figure 11: Global Market for Laboratory Nonhuman Primates, by Region, 2016-2023
    • Figure 12: Tissue Engineering Related Search Terms in PubMed, 2010-2018
    • Figure 13: Tissue Bioprinting Related Search Terms in PubMed, 2010-2018
    • Figure 14: Timeline for Possible Availability of 3D Printed Organs and Tissues for Humans, 2018-2043
    • Figure 15: Organ-on-Chip Related Search Terms in PubMed, 2010-2018
    • Figure 16: Investments in Organ-on-Chip Technology, by Company, 2008-2018
    • Figure 17: Global Market for Organs-on-Chips, 2017-2023
    • Figure 18: Timeline for Possible Availability of Organ-on-Chip Devices for Drug Screening in Human Patients, 2018-2030
    • Figure 19: Organoid Types Mentioned in PubMed Articles, 2010-2018
    • Figure 20: Mentions of Spheroids in PubMed Articles, 2010-2018
    • Figure 21: Global Market for Organoids, by Type, 2017-2023
    • Figure 22: Global Market for Animal Models, by End User, 2016-2023
    • Figure 23: Asia-Pacific Market for Laboratory Animal Models, by Type, 2016-2023
    • Figure 24: Australian Market for Laboratory Animal Models, by Type, 2016-2023
    • Figure 25: Chinese Market for Laboratory Animal Models, by Type, 2016-2023
    • Figure 26: Japanese Market for Laboratory Animal Models, by Type, 2016-2023
    • Figure 27: North American Market for Laboratory Animal Models, by Type, 2016-2023
    • Figure 28: U.S. Market for Laboratory Animal Models, by Type, 2016-2023
    • Figure 29: U.S. National Toxicology Program Funding for Toxicity Testing, 2013-2018
    • Figure 30: Canadian Market for Laboratory Animal Models, by Type, 2016-2023
    • Figure 31: Mexican Market for Laboratory Animal Models, by Type, 2016-2023
    • Figure 32: European Market for Laboratory Animal Models, by Type, 2016-2023
    • Figure 33: Great Britain Market for Laboratory Animal Models, by Type, 2016-2023
    • Figure 34: German Market for Laboratory Animal Models, by Type, 2016-2023
    • Figure 35: French Market for Laboratory Animal Models, by Type, 2016-2023
    • Figure 36: Rest of European Market for Laboratory Animal Models, by Type, 2016-2023
    • Figure 37: Middle Eastern and African Market for Laboratory Animal Models, by Type, 2016-2023
    • Figure 38: Israeli Market for Laboratory Animal Models, by Type, 2016-2023
    • Figure 39: South American Market for Laboratory Animal Models, by Type, 2016-2023
    • Figure 40: Brazilian Market for Laboratory Animal Models, by Type, 2016-2023
    • Figure 41: Global Number of Transplanted Organs, by Country, 2017
    • Figure 42: Charles River Laboratories: Number of Employees
    • Figure 43: Charles River Laboratories: RMS Company Yearly Revenues/Operating Income, by Quarter, 2016 and 2017
    • Figure 44: Charles River Laboratories: Revenue Share, by Segment, 2017
    • Figure 45: Envigo: Consolidated Revenue, by Segment, 2015-2018
    • Figure 46: Envigo: RMS Quarterly Revenue, 2015-2018
    • Figure 47: Merck & Co., Inc.: Revenue, by Region
目次
Product Code: PHM204A

Report Highlights:

The global market for laboratory animal models should grow from $5.9 billion in 2018 to $7.8 billion by 2023, increasing at a compound annual growth rate (CAGR) of 5.6% for the period of 2018-2023.

The global market for laboratory mice as an animal model should grow from $2.7 billion in 2018 to over $3.4 billion by 2023, increasing at a CAGR of 5.0% for the period of 2018-2023.

The global market for nonhuman primates as an animal model should grow from $1.7 billion in 2018 to $2.7 billion by 2023, increasing at a CAGR of 8.9% for the period of 2018-2023.

Report Scope:

The report describes three global markets: the animal model market, the 3D cultures market and the organoid market. The organoid market is described in more detail in a separate chapter of the report.

Report Includes:

  • 49 data tables 16 additional tables
  • Comprehensive overview of the global markets for laboratory animal models, 3D cell cultures and organoids
  • Analyses of global market trends, with data from 2016, 2017 and 2018; estimates for 2019 to 2022; and projections of compound annual growth rates (CAGRs) through 2023
  • Country specific data and analysis for Australia, China, Japan, U.S., Canada, Mexico, Brazil, U.K., France, Germany, Israel and Middle East
  • Information on current trends that significantly affect the basic research, biomedical and other industries where animals are used for toxicity testing and for evaluating the safety and metabolism of chemical compounds
  • Discussion of most significant trends in the 3D cell culture industry, including the bioprinting, organ-on-chip and organoid segments
  • Review of selected patents and patent applications on laboratory animal models for a brief period of 2006 to 2018
  • Company profiles of major market players within the industry, including Charles River Laboratories, Envigo, Crown Bioscience Inc., Genoway S.A., Taconic Biosciences and Merck & Co., Inc.

Table of Contents

Chapter 1: Introduction

  • Background
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources and Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

  • Laboratory Animal Models
  • 3D Cell Cultures

Chapter 3: Animal Model Market Technology Background

  • Methods of Animal Model and 3D Cell Culture Modification
    • Physical and Chemical Mutations
    • Targeted Mutations
  • Laboratory Animal Models
    • Market Definition
    • Animal Model Lines
    • Common Species of Laboratory Animals
    • Current Trends in Animal Model Usage

Chapter 4: 3D Cell Cultures Market Breakdown by Technology

  • 3D Cell Cultures
    • Spheroids
    • 3D Cultures vs. 2D Cultures vs. 2.5D Cultures
    • Scaffold-Based and Scaffold-Free 3D Cell Cultures
    • Scaffold-Free 3D Cell Cultures
    • Scaffold-Based 3D Cell Cultures
  • Tissue Engineering and Bioprinting
    • 3D Bioprinting Technology
  • Microfluidic Organ-on-Chip Platforms
    • Types of Organ-on-Chip Devices

Chapter 5: Organoids Market Breakdown by Technology

  • Organoids
    • Introduction
    • Organoids Technology and Principles
    • Organoid Technology Timeline
    • Types of Organoids
    • Organoid Biobanking and Libraries
    • Organoid System Complexity

Chapter 6: Market Breakdown by End User

  • Animal Models by End User
    • Academia and Research Institutions
    • Biomedical and Pharmaceutical Companies
    • Regulatory Processes and Routine Production
    • Cosmetics Industry
  • 3D Cell Cultures by End User
    • Basic Research
    • Biomedical and Pharma Companies
    • Regulatory Processes and Routine Production
    • Cosmetics Industry

Chapter 7: Market Breakdown by Application

  • Drug Discovery, Cancer Research and Personalized Medicine
    • Drug Discovery and High-throughput Compound Screening
    • Cancer Research
    • Personalized Medicine
    • Regenerative Medicine and Transplantations
  • Toxicity and Safety Testing
    • Drug Toxicity Testing

Chapter 8: Market Breakdown by Region

  • Asia-Pacific (APAC)
    • Australia
    • China
    • Japan
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Great Britain
    • Germany
    • France
    • Rest of Europe
  • Middle East and Africa (MEA)
    • Israel
  • South America
    • Brazil

Chapter 9: Patent Review/New Developments

Chapter 10: Analysis of Market Opportunities

  • Market Opportunities: Animal Models
  • Market Opportunities: 3D Cell Culture Segment
    • Organs-on-Chip
    • Organoids
    • Bioprinting
  • Advantages and Disadvantages of 3D Cell Cultures and Animal Models
    • Animal Models
    • 3D Cell Cultures in General
    • Organoids
    • Organs-on-Chip

Chapter 11: Profiles of Companies and Important Institutions

  • Animal Model Companies
    • ALPHAGENESIS INC.
    • CHARLES RIVER LABORATORIES INTERNATIONAL INC.
    • COVANCE INC.
    • CROWN BIOSCIENCE INC.
    • ENVIGO
    • GENOWAY S.A.
    • JACKSON LABORATORY
    • JANVIER LABS
    • OAK HILL GENETICS
    • PRIMGEN
    • TACONIC BIOSCIENCES
    • TRANSGENIC INC.
    • TRANSPOSAGEN BIOPHARMACEUTICALS INC.
  • Bioprinting and Regenerative Medicine Companies
    • ALLEVI
    • ASPECT BIOSYSTEMS LTD.
    • BIOINK SOLUTIONS INC.
    • CELLINK INC.
    • COLLPLANT HOLDINGS LTD.
    • EAST RIVER BIOSOLUTIONS/XYLYX BIO
    • EPIBONE
    • MATTEK CORP.
    • NANO 3D BIOSCIENCES INC.
    • ORGANOVO HOLDINGS INC.
    • PEPGEL LLC
    • REGENHU
    • TEVIDO BIODEVICES INC.
    • TISSUSE GMBH
  • Organ-on-Chip Companies
    • AXOSIM
    • EMULATE, INC.
    • KIRKSTALL LTD.
    • MICRONIT MICROTECHNOLOGIES
    • MIMETAS
    • TARA BIOSYSTEMS INC.
  • Organoid Companies
    • 3DNAMICS
    • CELLESCE
    • CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER
    • HUBRECHT ORGANOID TECHNOLOGY
    • QGEL
    • R&D SYSTEMS INC.
    • STEMCELL TECHNOLOGIES INC.
    • TREVIGEN INC.
  • Other 3D Cell Culture Companies
    • 3D BIOTEK LLC
    • ADVANCED BIOMATRIX INC.
    • HORIZON DISCOVERY GROUP PLC
    • IN SPHERO INC.
    • MERCK & CO., INC.
    • PROMOCELL GMBH
    • REPROCELL INC.
    • SYNTHECON, INC.
Back to Top